Indian Pharmaceutical Industry available through bharatbook.com

Indian Pharmaceutical Industry available through bharatbook.com Bharatbook added a new report on " Indian Pharmaceutical Industry " which gives an overview, Demand, Supply Trends and industry analysis reports. The Indian Pharmaceutical Industry..... Prescription (Rx) for growth The centre of gravity for global pharma industry is shifting eastwards as emerging economies are spending more money on healthcare as their citizens are living longer and growing wealthier. Simultaneously, cash strapped western governments are curbing healthcare related expenses and limiting outflow to state-funded medical programs. Moreover, the global pharmaceutical industry is witnessing a disproportionate scenario in recent years where there is large number of patent expiries coupled with lower introduction of innovative drugs. This is leading to global pharma companies strategically outsourcing their manufacturing and research jobs to countries like India while increasing their focus on introducing low cost generic drugs. http://www.bharatbook.com/marketresearch-reports/healthcare-market-research-report/indian-pharmaceutical-industry1.html Outsourcing activities can be in multiple segments right from the drug discovery till manufacturing of the final products. India has highest number of USFDA compliant manufacturing units (outside the US) to produce huge quantities of bulk drugs and formulation products complying stringent quality norms for global pharma companies. Several large global pharma companies have ventured into India through in-licensing route thereby taking advantage of local distribution network of Indian pharma companies. The demand for pharmaceutical products in India is significant and is driven by many factors like low drug penetration, rising middle-class & disposable income, increased government & private spending on healthcare infrastructure, increasing medical insurance penetration, changing demographic pattern and rise in chronic lifestyle-related diseases. market to market The Indian pharma industry is witnessing a shift in disease profile from the acute disease segment towards chronic diseases segment which is growing rapidly on the back of growing affluence, rise in life expectancy and the onset of lifestyle related conditions. In the coming years, chronic disease segment will drive the demand in the domestic formulations industry. Bio-pharmaceutical segment is currently experiencing double digit growth driven by a significant increase in revenue across business segment including statins, immunesuppressants and insulin. Major growth drivers for Indian biopharmaceutical industry include education and increased awareness of disease prevention, increase in disposable income and government participation in immunisation programmes. Continued growth is also expected in the diagnostic and therapeutic segments, primarily oncology, diabetes and vaccines market. The Indian CRAMS industry, valued at US$3.8 bn in CY2010 accounts for mere ~6% share of the global outsourcing market, indicating significant growth opportunity in this

Turn static files into dynamic content formats.

Create a flipbook